Previous Article | Next Article 
J Virol, June 1998, p. 5046-5055, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Effects of Mutations in Residues near the Active
Site of Human Immunodeficiency Virus Type 1 Integrase on Specific
Enzyme-Substrate Interactions
Jennifer L.
Gerton,1,
Sharron
Ohgi,2
Mari
Olsen,2
Joseph
DeRisi,3 and
Patrick
O.
Brown2,3,*
Howard Hughes Medical
Institute,2
Department of
Biochemistry,3 and
Department of
Microbiology and Immunology,1 Stanford
University Medical Center, Stanford, California 94305-5428
Received 27 June 1997/Accepted 16 February 1998
The phylogenetically conserved catalytic core domain of human
immunodeficiency virus type 1 (HIV-1) integrase contains elements necessary for specific recognition of viral and target DNA features. In
order to identify specific amino acids that determine substrate specificity, we mutagenized phylogenetically conserved residues that
were located in close proximity to the active-site residues in the
crystal structure of the isolated catalytic core domain of HIV-1
integrase. Residues composing the phylogenetically conserved DD(35)E
active-site motif were also mutagenized. Purified mutant proteins were
evaluated for their ability to recognize the phylogenetically conserved
CA/TG base pairs near the viral DNA ends and the unpaired dinucleotide
at the 5' end of the viral DNA, using disintegration substrates. Our
findings suggest that specificity for the conserved A/T base pair
depends on the active-site residue E152. The phenotype of IN(Q148L)
suggested that Q148 may be involved in interactions with the 5'
dinucleotide of the viral DNA end. The activities of some of the
proteins with mutations in residues in close proximity to the
active-site aspartic and glutamic acids were salt sensitive, suggesting
that these mutations disrupted interactions with DNA.
*
Corresponding author. Mailing address: B253 Beckman
Center, Stanford University Medical Center, Stanford, CA 94305-5428. Phone: (650) 723-0039. Fax: (650) 723-1399. E-mail:
pbrown{at}cmgm.stanford.edu.

Present address: Department of Biology, University of North
Carolina, Chapel Hill, NC 27599-3280.
J Virol, June 1998, p. 5046-5055, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hobaika, Z., Zargarian, L., Boulard, Y., Maroun, R. G., Mauffret, O., Fermandjian, S.
(2009). Specificity of LTR DNA recognition by a peptide mimicking the HIV-1 integrase {alpha}4 helix. Nucleic Acids Res
0: gkp824v1-gkp824
[Abstract]
[Full Text]
-
Choudhary, S. K., Rezk, N. L., Ince, W. L., Cheema, M., Zhang, L., Su, L., Swanstrom, R., Kashuba, A. D. M., Margolis, D. M.
(2009). Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4+ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2-/-{gamma}c-/- Mouse. J. Virol.
83: 8254-8258
[Abstract]
[Full Text]
-
Dicker, I. B., Terry, B., Lin, Z., Li, Z., Bollini, S., Samanta, H. K., Gali, V., Walker, M. A., Krystal, M. R.
(2008). Biochemical Analysis of HIV-1 Integrase Variants Resistant to Strand Transfer Inhibitors. J. Biol. Chem.
283: 23599-23609
[Abstract]
[Full Text]
-
Malet, I., Delelis, O., Valantin, M.-A., Montes, B., Soulie, C., Wirden, M., Tchertanov, L., Peytavin, G., Reynes, J., Mouscadet, J.-F., Katlama, C., Calvez, V., Marcelin, A.-G.
(2008). Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro. Antimicrob. Agents Chemother.
52: 1351-1358
[Abstract]
[Full Text]
-
Dicker, I. B., Samanta, H. K., Li, Z., Hong, Y., Tian, Y., Banville, J., Remillard, R. R., Walker, M. A., Langley, D. R., Krystal, M.
(2007). Changes to the HIV Long Terminal Repeat and to HIV Integrase Differentially Impact HIV Integrase Assembly, Activity, and the Binding of Strand Transfer Inhibitors. J. Biol. Chem.
282: 31186-31196
[Abstract]
[Full Text]
-
Agapkina, J., Smolov, M., Barbe, S., Zubin, E., Zatsepin, T., Deprez, E., Le Bret, M., Mouscadet, J.-F., Gottikh, M.
(2006). Probing of HIV-1 Integrase/DNA Interactions Using Novel Analogs of Viral DNA. J. Biol. Chem.
281: 11530-11540
[Abstract]
[Full Text]
-
Johnson, A. A., Santos, W., Pais, G. C. G., Marchand, C., Amin, R., Burke, T. R. Jr., Verdine, G., Pommier, Y.
(2006). Integration Requires a Specific Interaction of the Donor DNA Terminal 5'-Cytosine with Glutamine 148 of the HIV-1 Integrase Flexible Loop. J. Biol. Chem.
281: 461-467
[Abstract]
[Full Text]
-
Diamond, T. L., Bushman, F. D.
(2005). Division of Labor within Human Immunodeficiency Virus Integrase Complexes: Determinants of Catalysis and Target DNA Capture. J. Virol.
79: 15376-15387
[Abstract]
[Full Text]
-
Lu, R., Ghory, H. Z., Engelman, A.
(2005). Genetic Analyses of Conserved Residues in the Carboxyl-Terminal Domain of Human Immunodeficiency Virus Type 1 Integrase. J. Virol.
79: 10356-10368
[Abstract]
[Full Text]
-
Lu, R., Limon, A., Ghory, H. Z., Engelman, A.
(2005). Genetic Analyses of DNA-Binding Mutants in the Catalytic Core Domain of Human Immunodeficiency Virus Type 1 Integrase. J. Virol.
79: 2493-2505
[Abstract]
[Full Text]
-
Lu, R., Limon, A., Devroe, E., Silver, P. A., Cherepanov, P., Engelman, A.
(2004). Class II Integrase Mutants with Changes in Putative Nuclear Localization Signals Are Primarily Blocked at a Postnuclear Entry Step of Human Immunodeficiency Virus Type 1 Replication. J. Virol.
78: 12735-12746
[Abstract]
[Full Text]
-
Ikeda, T., Nishitsuji, H., Zhou, X., Nara, N., Ohashi, T., Kannagi, M., Masuda, T.
(2004). Evaluation of the Functional Involvement of Human Immunodeficiency Virus Type 1 Integrase in Nuclear Import of Viral cDNA during Acute Infection. J. Virol.
78: 11563-11573
[Abstract]
[Full Text]
-
Gao, K., Wong, S., Bushman, F.
(2004). Metal Binding by the D,DX35E Motif of Human Immunodeficiency Virus Type 1 Integrase: Selective Rescue of Cys Substitutions by Mn2+ In Vitro. J. Virol.
78: 6715-6722
[Abstract]
[Full Text]
-
Svarovskaia, E. S., Barr, R., Zhang, X., Pais, G. C. G., Marchand, C., Pommier, Y., Burke, T. R. Jr., Pathak, V. K.
(2004). Azido-Containing Diketo Acid Derivatives Inhibit Human Immunodeficiency Virus Type 1 Integrase In Vivo and Influence the Frequency of Deletions at Two-Long-Terminal-Repeat-Circle Junctions. J. Virol.
78: 3210-3222
[Abstract]
[Full Text]
-
Harper, A. L., Skinner, L. M., Sudol, M., Katzman, M.
(2001). Use of Patient-Derived Human Immunodeficiency Virus Type 1 Integrases To Identify a Protein Residue That Affects Target Site Selection. J. Virol.
75: 7756-7762
[Abstract]
[Full Text]
-
Meiering, C. D., Comstock, K. E., Linial, M. L.
(2000). Multiple Integrations of Human Foamy Virus in Persistently Infected Human Erythroleukemia Cells. J. Virol.
74: 1718-1726
[Abstract]
[Full Text]
-
Chen, H., Wei, S.-Q., Engelman, A.
(1999). Multiple Integrase Functions Are Required to Form the Native Structure of the Human Immunodeficiency Virus Type I Intasome. J. Biol. Chem.
274: 17358-17364
[Abstract]
[Full Text]
-
van den Ent, F. M. I., Vos, A., Plasterk, R. H. A.
(1999). Dissecting the Role of the N-Terminal Domain of Human Immunodeficiency Virus Integrase by trans-Complementation Analysis. J. Virol.
73: 3176-3183
[Abstract]
[Full Text]